GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,000 | -28.6% | 120 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $7,000 | -12.5% | 120 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $8,000 | +33.3% | 120 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | -40.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,000 | +66.7% | 120 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $6,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | 0.0% | 120 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $6,000 | +20.0% | 120 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $5,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |